Constellation Brands
- Market cap
- 20.03B
- P/E (TTM)i
- 10.60
- P/Bi
- 2.33
- EPSi
- 9.61
- Div yieldi
- 3.46%
- 52W posi
- 14%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 94.76% -0.01pp
- Institutions
- 1,222 -4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 38 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| Robert Sands | Director | 0.27% |
| Richard Sands | Non-Executive Director | 0.12% |
| James Sabia | Executive VP, President of Beer Division & President of Crown | 0.01% |
| Garth Hankinson | Chief Financial Officer | 0.01% |
| William Newlands | Chief Executive Officer | 0.01% |
| James Bourdeau | Executive Vice President | 0.01% |
| Mallika Monteiro | Executive VP and Chief Growth, Strategy & Digital Officer | 0.01% |
| Jeffrey LaBarge | Senior VP & Senior Legal Counsel of Beer Division | 0.00% |
| Daniel McCarthy | Independent Director | 0.00% |
| Samuel Glaetzer | Senior Vice President of Global Operations - Wine + Spirits Division | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-21 | Richard Sands | Non-Executive Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | Robert Sands | Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | William Giles | Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | Daniel McCarthy | Independent Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | Christopher Baldwin | Non-Executive Chairperson | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | Jennifer Daniels | Independent Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | Ernesto Hernandez | Independent Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | Luca Zaramella | Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | E. Flatley | Independent Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | Christina Clark | Independent Director | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-21 | Jose Madero Garza | Interim Independent Board Chair | Other Derivative Acquisition | +1,400 | -- |
| 2026-07-09 | Richard Sands | Non-Executive Director | Derivative Exercise and Retained | +1,114 | -- |
| 2026-07-09 | Robert Sands | Director | Derivative Exercise and Retained | +1,114 | -- |
| 2026-07-09 | William Giles | Director | Derivative Exercise and Retained | +1,114 | -- |
| 2026-07-09 | Daniel McCarthy | Independent Director | Derivative Exercise and Retained | +1,114 | -- |
| 2026-07-09 | Christopher Baldwin | Non-Executive Chairperson | Derivative Exercise and Retained | +1,114 | -- |
| 2026-07-09 | Jennifer Daniels | Independent Director | Derivative Exercise and Retained | +1,114 | -- |
| 2026-07-09 | Ernesto Hernandez | Independent Director | Derivative Exercise and Sale | -15 | $134.06 |
| 2026-07-09 | Ernesto Hernandez | Independent Director | Derivative Exercise and Retained | +1,099 | -- |
| 2026-07-09 | Luca Zaramella | Director | Derivative Exercise and Retained | +1,114 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:38:07 · For reference only, not investment advice and not tailored to your situation.